Medicare Enrolled

Dr. Brad Brazeal, MD

Psychiatry · Palestine, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
300 WILLOW CREEK PKWY, Palestine, TX 75801
9037231940
Registered in NPPES since 2005
NPI: 1265415640 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brazeal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brazeal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brazeal

Dr. Brad Brazeal is a psychiatry specialist in Palestine, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Brazeal performed 839 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Brazeal received a total of $16,947 from 40 pharmaceutical and/or device companies across 944 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brazeal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 12% volume in TX $16,947 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
839
Medicare services
Top 12% in TX for psychiatry
Not available
Unique patients (not deduplicated)
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
414 $92 $204
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
413 $51 $170
New patient office visit, complex (60-74 min) 12 $168 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,947
Total received (2018-2024)
Avg $2,421/year across 7 years
Top 5% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
944
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,164
2023
$2,702
2022
$2,282
2021
$2,595
2020
$2,139
2019
$2,847
2018
$2,217

Payments by company (2024)

Teva Pharmaceuticals USA, Inc.
$622
Neurocrine Biosciences, Inc.
$328
ABBVIE INC.
$309
Janssen Scientific Affairs, LLC
$200
Axsome Therapeutics, Inc.
$176
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$118
Alkermes, Inc.
$116
Lundbeck LLC
$83
Otsuka America Pharmaceutical, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$65
Janssen Pharmaceuticals, Inc
$41
Almatica Pharma LLC
$19
IDORSIA PHARMACEUTICALS US INC
$18
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$2,263
Neurocrine Biosciences, Inc.
$1,658
Otsuka America Pharmaceutical, Inc.
$1,566
Lundbeck LLC
$915
ITI, Inc.
$880
Alkermes, Inc.
$879
Janssen Pharmaceuticals, Inc
$867
Daiichi Sankyo Inc.
$717
Takeda Pharmaceuticals U.S.A., Inc.
$691
Sunovion Pharmaceuticals Inc.
$668
AbbVie Inc.
$640
Allergan Inc.
$639
ABBVIE INC.
$622
Avanir Pharmaceuticals, Inc.
$583
Vanda Pharmaceuticals Inc.
$520
Axsome Therapeutics, Inc.
$511
Amgen Inc.
$425
Allergan, Inc.
$376
Novartis Pharmaceuticals Corporation
$205
Janssen Scientific Affairs, LLC
$200
JAZZ PHARMACEUTICALS INC.
$178
Eisai Inc.
$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$118
Bausch Health US, LLC
$116
Ironshore Pharmaceuticals Inc.
$69
IDORSIA PHARMACEUTICALS US INC
$60
ARBOR PHARMACEUTICALS, INC.
$54
Shire North American Group Inc
$45
Almatica Pharma LLC
$43
PFIZER INC.
$42
Merck Sharp & Dohme Corporation
$38
Arbor Pharmaceuticals, Inc.
$25
Brainsway USA Inc
$25
Alfasigma USA, Inc.
$24
Assertio Therapeutics, Inc.
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
ASSERTIO THERAPEUTICS, Inc.
$20
Indivior Inc.
$19
EISAI INC.
$15
Pernix Therapeutics Holdings, Inc.
$15
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · AIMOVIG · AJOVY · APLENZIN · ARISTADA · AUSTEDO · Aimovig · Aristada 441 mg · Austedo XR · Auvelity · BELSOMRA · BRINTELLIX · Brainsway Deep TMS · CAPLYTA · Cambia · Dayvigo · EMBEDA · Fanapt · HETLIOZ · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · MYDAYIS · Morphabond ER · Movantik · NUEDEXTA · Nuedexta · PERSERIS · QULIPTA · QUVIVIQ · REXULTI · SILENOR · SPRAVATO · SUNOSI · Sunosi · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VRAYLAR · VYVANSE · XYWAV · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Palestine?
Compare psychiatrists in the Palestine area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
9
County median income
$58,846
Nearest hospital to ZIP centroid (approximate)
PALESTINE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brazeal is a clinical cardiology specialist, with above-average Medicare volume (top 12% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brazeal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Brazeal performed 414 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Brazeal receive payments from pharmaceutical companies?
Yes. Dr. Brazeal received a total of $16,947 from 40 companies across 944 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brazeal's costs compare to other psychiatrists in Palestine?
Dr. Brazeal's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brazeal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →